Endoscopic Gastric Tubulization for Morbid Obesity
Endoscopic Gastric Tubulization
Recruiting
Observational Study
Morbid Obesity
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 65
- Sex
- Any
- Study type
- Observational
- Participants needed
- 300 (estimated)
- Sponsor
- IHU Strasbourg · Other
Who this trial is looking for
This trial is looking for adults with morbid obesity who are scheduled for an endoscopic gastric tubulization at the Nouvel Hôpital Civil in Strasbourg, France. Participants will have their health data collected before the procedure and for two years afterward to assess weight loss and other health improvements.
Are You a Good Fit for This Trial?
You may be able to join if
- I am an adult scheduled for an endoscopic gastric tubulization
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
Endoscopic gastric tubulization is currently proposed in the Digestive Surgery Department of the Nouvel Hôpital Civil, Strasbourg, France, to adult patients with morbid obesity. The procedure is performed using the CE marked endoscopic suture device Overstitch (Apollo Endosurgery, Austin, Tx. USA). It is standard practice since October 2016.
The objective of this study is to prospectively collect…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients scheduled for an endoscopic gastric tubulization in the Nouvel Hôpital Civil, Strasbourg, France
Contacts